Literature DB >> 4587632

Non-randomized controls in cancer clinical trials.

E A Gehan, E J Freireich.   

Abstract

Entities:  

Mesh：

Year:  1974        PMID： 4587632     DOI： 10.1056/NEJM197401242900405

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  28 in total

1.  Assessing effects on long-term survival after early termination of randomized trials.

Authors:  Y Shen; T R Fleming
Journal:  Lifetime Data Anal       Date:  1999       Impact factor: 1.588

2.  Sir Austin Bradford Hill and the progress of medical science.

Authors:  R Doll
Journal:  BMJ       Date:  1992 Dec 19-26

Review 3.  Substituting placebo for established, effective therapy: why not?

Authors:  Stan Shapiro; Dean Fergusson; Kathleen Cranley Glass
Journal:  CMAJ       Date:  2010-06-14       Impact factor: 8.262

4.  Clinical trials and the acceptance of uncertainty.

Authors:  M B Bracken
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-02

Review 5.  Precision medicine needs randomized clinical trials.

Authors:  Everardo D Saad; Xavier Paoletti; Tomasz Burzykowski; Marc Buyse
Journal:  Nat Rev Clin Oncol       Date:  2017-02-07       Impact factor: 66.675

6.  The uptake of anticancer drugs by tumor tissues and lymph node and the effectiveness of postoperative adjuvant chemotherapy on survival time.

Authors:  S Arima; K Futami; H Toriya; H Shimura
Journal:  Jpn J Surg       Date:  1989-03

Review 7.  Clinical Trials in Neurovirology: Successes, Challenges, and Pitfalls.

Authors:  Dietrich Haubenberger; David B Clifford
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

Review 8.  [Prospective controlled clinical trials in surgery. controversial issues in motivation and performance (author's transl)].

Authors:  W Lorenz; H Rohde
Journal:  Klin Wochenschr       Date:  1979-04-01

9.  Immunotherapy: its possible application in the management of large-bowel cancer.

Authors:  G M Mavligit; J U Guttermann; M A Burgess; J F Speer; R C Reed; R C Martin; C M McBride; E M Copeland; E A Gehan; E M Hersh
Journal:  Am J Dig Dis       Date:  1974-11

10.  Evidence that treatment with vaccinia melanoma cell lysates (VMCL) may improve survival of patients with stage II melanoma. Treatment of stage II melanoma with viral lysates.

Authors:  P Hersey; A Edwards; A Coates; H Shaw; W McCarthy; G Milton
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.